Table 4.
Patient group | Brain natriuretic peptide
|
N-terminal atrial natriuretic peptide
|
|||||
---|---|---|---|---|---|---|---|
Optimal threshold (pg/ml} | Positive predictive value (95% CI) | Negative predictive value (95% CI) | Optimal threshold (ng/ml) | Positive predictive value (95% CI) | Negative predictive value (95% CI) | ||
Moderate or severe left ventricular dysfunction | 46 | 0.69 (0.44 to 0.94) | 0.55 (0.42 to 0.68) | 4.4 | 0.52 (0.32 to 0.72) | 0.51 (0.36 to 0.66) | |
Severe left ventricular dysfunction | 32 | 0.35 (0.12 to 0.58) | 0.92 (0.81 to 1.03) | 1.4 | 0.22 (0.8 to 0.36) | 1.00 | |
Fractional shortening <25% | 46 | 0.56 (0.24 to 0.88) | 0.86 (0.74 to 0.98) | 5.4 | 0.31 (0.08 to 0.54) | 0.82 (0.68 to 0.96) |
Optimal indicates the peptide concentration giving the best combination of sensitivity and specificity.